About Acuitas Therapeutics
Acuitas Therapeutics develops proprietary lipid nanoparticle (LNP) systems for mRNA and gene therapy delivery, licensing LNP technology to vaccine and gene therapy companies.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Acuitas Therapeutics. Response typically within 48 hours.